Our multi-disciplinary team offers best in class health economics and outcomes research (HEOR) and market access services to the world’s leading pharmaceutical and medical device companies. We balance scientific rigor with commercial awareness, differentiating ourselves from our competition through innovation, technical excellence, and design.
To find out more about the market access roadmap service please get in touch
Our in-house team of strategists, health economists, researchers, medical writers, systematic reviewers, statisticians, designers, developers, and project managers allows you to achieve all aspects of your HEOR and market access goals, eliminating the need to commission several different agencies.
The US-based, independently operated Institute for Clinical and Economic Review (ICER) has established a partnership with the UK’s National Institute for Health Care and Excellence (NICE) and the Canadian...
What does patient-centricity really mean in clinical outcomes research? Patients regularly invest their time and effort into qualitative patient- interview studies to provide COA researchers with a deep unders...
We are part of Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd.
DRG offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 1,000 employees across 17 offices in North America, Europe and Asia.Our Company